Angioslide is a medical device company that develops Embolic Capture Angioplasty device.
Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now capture and remove embolic particles during angioplasty procedures.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 1, 2015 | Series E | $3M | 2 | — | — | Detail |
| Jan 3, 2013 | Series D | $6.30M | 2 |
Triventures
|
— | Detail |
| Aug 1, 2009 | Series C | $8.25M | 1 | — | — | Detail |
| May 1, 2008 | Series B | $8.60M | 1 | — | — | Detail |
| Dec 1, 2006 | Series A | $4M | 1 |
Viola Partners
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Viola Partners
|
— | Series E |
Triventures
|
— | Series E |